Business
Avivagen Provides Further Detail on its Third Quarter Results Ending July 31, 2021
Avivagen Provides Further Detail on its Third Quarter Results Ending July 31, 2021.
About this update from Avivagen, Inc.
[{"type":"text","content":"\nAvivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), after releasing its third quarter results yesterday is pleased to provide further detail about product shipments during the third quarter in order to address questions it has received from investors following its earlier press release.\n\nThe announced 4.4-tonne order for OxC-betaTM Livestock was shipped to the Philippines during the third quarter, the 3.5-tonne shipment referred to in the prior press release is currently being held by Avivagen’s Mexican distribution partner pending delivery and payment by the customer and the 500 kg order for OxC-betaTM Livestock mentioned in the previous press release was not shipped during Avivagen’s third quarter.\n\nAbout Avivagen\n\nAvivagen is a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that, by safely supporting immune function, promote general health and performance. It is a public corporation traded on the TSX Venture Exchange under the symbol VIV and is headquartered in Ottawa, Canada, based in partnership facilities of the National Research Council of Canada. For more information, visit www.avivagen.com. The contents of the website are expressly not incorporated by reference in this press release.\n\nAbout OxC-beta™ Technology and OxC-beta™ Livestock\n\nAvivagen’s OxC-beta™ technology is derived from Avivagen discoveries about β-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colours. Through support of immune function the technology provides a non-antibiotic means of promoting health and growth. OxC-beta™ Livestock is a proprietary product shown to be an effective and economic alternative to the antibiotics commonly added to livestock feeds. The product is currently available for sale in the United States, Philippines, Mexico, Taiwan, New Zealand, Thailand, Brazil, Australia, and Malaysia.\n\nAvivagen’s OxC-beta™ Livestock product is safe, effective and could fulfill the global mandate to remove all in-feed antibiotics as growth promoters. Numerous international livestock trials with poultry and swine using OxC-beta™ Livestock have proven that the product performs as well as, and, sometimes, in some aspects, better than...